Loading paragraph...
Today's Biggest Stock Gainers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| PCSA | Processa Pharmaceuticals | $6.48 | $3.47 | 115.50% | 32.1M | $170M | $2.74$27.00 |
| MGRT | Mega Fortune | $8.32 | $2.97 | 55.51% | 1.2M | $74M | $1.50$9.68 |
| ISPO | Inspirato | $4.17 | $1.33 | 46.76% | 8.7M | $36M | $2.19$7.17 |
| GVH | Globavend | $3.80 | $0.85 | 28.81% | 433.1K | $3.7M | $2.95$364.00 |
| DBVT | Dbv Technologies | $23.00 | $5.02 | 27.92% | 3.5M | $722M | $2.74$26.19 |
| BENF | Beneficient | $4.70 | $0.96 | 25.67% | 243.4K | $415M | $1.75$12.48 |
| KLRS | Kalaris Therapeutics | $10.67 | $2.01 | 23.19% | 490K | $162M | $2.14$12.90 |
| DDL | Dingdong (Cayman) | $2.81 | $0.53 | 23.03% | 6.6M | $412M | $1.65$4.23 |
| LPCN | Lipocine | $3.70 | $0.55 | 17.46% | 236.1K | $17M | $2.52$5.50 |
| QNRX | Quoin Pharmaceuticals | $13.75 | $2.03 | 17.32% | 81.8K | $6.9M | $5.01$41.80 |
Related Articles
Featured Article
Could Recursion Pharmaceuticals Be the Next Big Artificial Intelligence (AI) Stock?
Prosper Junior Bakiny|Nov 24, 2025
Getting in on the ground floor would be great, but only if there's massive upside ahead for the company.
Is Recursion Pharmaceuticals a Meme Stock?
Prosper Junior Bakiny|Nov 19, 2025
The answer seems straightforward enough.
Down 75% in 12 Months, Can Iovance Biotherapeutics Stock Turn Things Around?
David Jagielski, CPA|Nov 11, 2025
Iovance has a long way to go to get to a break-even point, but the company has been showing progress.
Advertisement
2 Small-Cap Stocks With Far More Upside Than Any "Magnificent Seven" Stock, According to Wall Street
Prosper Junior Bakiny|Nov 7, 2025
Wall Street may be overestimating these companies' potential.
3 Things Investors Need to Know About Recursion Pharmaceuticals
Prosper Junior Bakiny|Nov 4, 2025
Can this under-the-radar stock be a great way to cash in on AI?
Could Recursion Pharmaceuticals Be the Next Big Artificial Intelligence (AI) Stock?
David Jagielski, CPA|Oct 31, 2025
Recursion uses artificial intelligence to help advance drug discovery, which could be a massive opportunity in healthcare.
Up 25% in 1 Month, Is This Stock a Buy?
Prosper Junior Bakiny|Oct 21, 2025
It might look like this beaten-down AI-focused company is finally bouncing back, but don't be too quick to pull the trigger.
Better Beaten-Down Stock: Iovance Biotherapeutics vs. Teladoc Health
Prosper Junior Bakiny|Oct 17, 2025
Is there a glimmer of hope for either of these underperforming healthcare companies?
Where Will Recursion Pharmaceuticals Be in 5 Years?
Prosper Junior Bakiny|Sep 28, 2025
Could investing in this stock be an underrated way to profit from the rapidly expanding AI industry?
The Biotech Stock That's Too Risky for Most Investors
Cory Renauer|Sep 28, 2025
It's unclear how long it's going to be before this company has a product to sell.
